Using the BLISS-LN phase 3 study of belimumab, investigators studied biomarker associations with kidney response in lupus nephritis.

Significantly greater decrease seen in lifetime ASCVD risk following MBS versus GLP-1 RA therapy, plus greater percent total body weight loss.

An umbrella review in JAMA Network Open finds low credibility for most noncardiometabolic effects of GLP-1RAs in clinical studies.

Greater increases seen in amputation rates among opioid-related hospitalizations at the national level and in Northeast, West census regions.

The storm had strewn fallen trees across most roads, wiped out phone and internet communications, and put some neighborhoods near her Asheville home underwater.

The Dialysafe trial aimed to reduce episodes of intradialytic hypotension during hemodialysis sessions at the clinic level.

Cardiogenic shock is frequently complicated by acute kidney injury, so investigators set out to identify predictors.

High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 diabetes and obesity.

Pulmonary hypertension risk increases with the severity of CKD, and affects up to two-thirds of patients receiving hemodialysis.

Drug-induced acute kidney injury (AKI) frequently develops in hospitalized patients receiving nephrotoxic therapy.